Minerva Surgical Statistics
Share Statistics
Minerva Surgical has 8.88M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 8.88M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.73M |
| Failed to Deliver (FTD) Shares | 400 |
| FTD / Avg. Volume | 459.77% |
Short Selling Information
The latest short interest is 37.42K, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 37.42K |
| Short % of Shares Out | 0.42% |
| Short % of Float | 1.37% |
| Short Ratio (days to cover) | 0.51 |
Valuation Ratios
The PE ratio is -0.19 and the forward PE ratio is null.
| PE Ratio | -0.19 |
| Forward PE | null |
| PS Ratio | 0.13 |
| Forward PS | 0 |
| PB Ratio | 0.37 |
| P/FCF Ratio | -0.18 |
| PEG Ratio | n/a |
Enterprise Valuation
Minerva Surgical Inc. has an Enterprise Value (EV) of 39.17M.
| EV / Earnings | -1.15 |
| EV / Sales | 0.78 |
| EV / EBITDA | -1.95 |
| EV / EBIT | -1.27 |
| EV / FCF | -1.1 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 2.29.
| Current Ratio | 2.53 |
| Quick Ratio | 1.35 |
| Debt / Equity | 2.29 |
| Total Debt / Capitalization | 69.6 |
| Cash Flow / Debt | -0.9 |
| Interest Coverage | -9.59 |
Financial Efficiency
Return on equity (ROE) is -1.99% and return on capital (ROIC) is -54.35%.
| Return on Equity (ROE) | -1.99% |
| Return on Assets (ROA) | -0.5% |
| Return on Capital (ROIC) | -54.35% |
| Revenue Per Employee | 289.05K |
| Profits Per Employee | -196.05K |
| Employee Count | 174 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.37 |
Taxes
| Income Tax | 11.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 4.6, so Minerva Surgical 's price volatility has been higher than the market average.
| Beta | 4.6 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 6.17 |
| Average Volume (20 Days) | 87 |
Income Statement
In the last 12 months, Minerva Surgical had revenue of $50.29M and earned -$34.11M in profits. Earnings per share was $-23.68.
| Revenue | 50.29M |
| Gross Profit | 27.24M |
| Operating Income | -30.90M |
| Net Income | -34.11M |
| EBITDA | -20.07M |
| EBIT | -30.90M |
| Earnings Per Share (EPS) | -23.68 |
Balance Sheet
The company has $6.94M in cash and $39.69M in debt, giving a net cash position of -$32.75M.
| Cash & Cash Equivalents | 6.94M |
| Total Debt | 39.69M |
| Net Cash | -32.75M |
| Retained Earnings | -283.67M |
| Total Assets | 72.78M |
| Working Capital | 18.75M |
Cash Flow
In the last 12 months, operating cash flow was -$35.57M and capital expenditures -$73.00K, giving a free cash flow of -$35.64M.
| Operating Cash Flow | -35.57M |
| Capital Expenditures | -73.00K |
| Free Cash Flow | -35.64M |
| FCF Per Share | -24.74 |
Margins
Gross margin is 54.17%, with operating and profit margins of -61.44% and -67.83%.
| Gross Margin | 54.17% |
| Operating Margin | -61.44% |
| Pretax Margin | -67.8% |
| Profit Margin | -67.83% |
| EBITDA Margin | -39.91% |
| EBIT Margin | -61.44% |
| FCF Margin | -70.86% |
Dividends & Yields
UTRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | -4013513.51% |
Analyst Forecast
Currently there are no analyst rating for UTRS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 2, 2023. It was a backward split with a ratio of 1:20.
| Last Split Date | Oct 2, 2023 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -6.27 |
| Piotroski F-Score | 2 |